Omnicell (OMCL) Cash from Operations (2010 - 2026)
Omnicell's (OMCL) quarterly Cash from Operations came in at $68.3 million in Q2 2026, up 59.78% year-over-year from $42.8 million in Q2 2025, and up 25.35% quarter-over-quarter from $54.5 million in Q1 2026.
Analysis
Omnicell (OMCL) Cash from Operations (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Cash from Operations for 17 consecutive years, with $68.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations rose 59.78% year-over-year to $68.3 million in Q2 2026; TTM through Jun 2026 was $181.4 million, a 22.8% increase from a year earlier, with the FY2025 full-year figure at $127.3 million, down 32.19% from the prior year.
- Cash from Operations was $68.3 million for Q2 2026 at Omnicell, up from $54.5 million in the prior quarter.
- Over five years, Cash from Operations peaked at $82.2 million in Q4 2022 and troughed at -$16.0 million in Q1 2022.
- A 5-year average of $38.7 million and a median of $40.6 million in 2023 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 127.86% in 2022 and soared 863.3% in 2023, its largest moves.
- Over 5 years, Cash from Operations stood at $82.2 million in 2022, then slumped by 53.24% to $38.4 million in 2023, then surged by 46.6% to $56.3 million in 2024, then plunged by 46.1% to $30.4 million in 2025, then surged by 125.06% to $68.3 million in 2026.
- The last three Cash from Operations figures came in at $68.3 million (Q2 2026), $54.5 million (Q1 2026), and $30.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 2.49 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 1.06 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 1.79 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 1.26 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.47 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 651.90 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 510.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 269.20 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 454.63 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 68.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.31 Mn |
| Mar 31, 2026 | 54.50 Mn |
| Dec 31, 2025 | 30.35 Mn |
| Sep 30, 2025 | 28.27 Mn |
| Jun 30, 2025 | 42.76 Mn |
| Mar 31, 2025 | 25.92 Mn |
| Dec 31, 2024 | 56.32 Mn |
| Sep 30, 2024 | 22.75 Mn |
| Jun 30, 2024 | 58.70 Mn |
| Mar 31, 2024 | 49.95 Mn |
| Dec 31, 2023 | 38.41 Mn |
| Sep 30, 2023 | 57.01 Mn |
| Jun 30, 2023 | 72.90 Mn |
| Mar 31, 2023 | 12.77 Mn |
| Dec 31, 2022 | 82.15 Mn |
| Sep 30, 2022 | 21.18 Mn |
| Jun 30, 2022 | -9.55 Mn |
| Mar 31, 2022 | -16.00 Mn |
| Dec 31, 2021 | 59.63 Mn |
| Sep 30, 2021 | 42.99 Mn |